View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
  2. Company News
June 15, 2018updated 27 Jul 2018 7:37am

Deals this week: Fresenius Medical Care, Senseonics, Sonion

Fresenius Medical Care has signed a global partnership agreement to commercialise Humacyte's investigational human acellular vessel Humacyl.

Fresenius Medical Care has signed a global partnership agreement to commercialise Humacyte ‘s investigational human acellular vessel Humacyl.

Fresenius Medical Care will be responsible for its marketing and distribution following the approval by health authorities.

The transaction will be closed in July, subject to customary closing conditions and other regulatory approvals.

Based in Germany, Fresenius Medical Care is a supplier of renal dialysis products, while Humacyte is a US-based medical research and development company focused on novel technologies.

The partnership will enable Humacyte to advance the development of Humacyl and continue the development of its future pipeline products.

Senseonics has entered an agreement to integrate its Eversense Continuous Glucose Monitoring (CGM) system with Beta Bionics ‘s bionic pancreas system.

“The partnership will enable Humacyte to advance the development of Humacyl and continue the development of its future pipeline products.”

Based in the US, Senseonics focuses on the development of glucose monitoring products, while Beta Bionics , also based in the US, is a developer of bionic pancreas system iLet.

Sonion and Valencell have partnered to expand the use of biometric sensors for hearing instruments in the health, medical and consumer device markets.

Valencell will provide biometric sensor modules for hearables and wearables, which Sonion will optimise for size and cost for in-ear and on-ear applications, as part of the collaboration.

Valencell has also secured an undisclosed investment from Sonion through the strategic partnership.

Based in the US, Valencell is a manufacturer of wearable biometric sensor systems, while Sonion , also based in the US, is a manufacturer of micro-acoustic components for hearing aids.

The partnership will enable Valencell to strengthen its position in the hearables and hearing health markets.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network